| Code | 8980E | ||||||||||
| MA number | 69/0136/04-S | ||||||||||
| Product Form: | pas ord 40x3 mg (obal papier) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Angelini Pharma Österreich GmbH, Austria | ||||||||||
| Therapeutic Class: | 69 - OTORHINOLARYNGOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Route of admin.: | Oropharyngeal use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 26.04.2004 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| PIL: |
|
| SPC: |
|
| Safety feature | No |
| Data update: | 07.02.2025 |